{
    "2020-06-29": [
        [
            {
                "time": "2020-05-01",
                "original_text": "U.S. FDA allows emergency use of Danaher's COVID-19 antibody test",
                "features": {
                    "keywords": [
                        "FDA",
                        "emergency use",
                        "Danaher",
                        "COVID-19",
                        "antibody test"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Tandem Diabetes Care",
                        "Integrated Technologies",
                        "Automated Insulin Delivery Systems"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-20",
                "original_text": "These 6 health-care stocks are ‘buys’ because they can thrive under either Trump or Biden",
                "features": {
                    "keywords": [
                        "health-care stocks",
                        "buys",
                        "Trump",
                        "Biden"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}